Skip to Main Content

Paper Details

Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.
Leukemia
53
2018
Author NameAffiliation
James M OlsonClinical Research Division, Fred Hutchinson Cancer Research Center
James M OlsonUniversity of Washington
  • 1 - 2

Datasets

Release 1.2